Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Maria Velleca"'
Autor:
Kaitlyn Dawkins, Maria Velleca, Leena Patel, Giuseppe Stabile, Ahmed Hussein, Dhiraj Gupta, Laura Goldstein, Tom Wei, Paul Spin
Publikováno v:
Advances in Therapy
Introduction Both radiofrequency (RF) and cryoballoon (CB) ablation are treatment options for persistent atrial fibrillation (PsAF). An important recent innovation in RF ablation is Ablation Index (AI), known also as the VISITAG SURPOINT™ Module, a
Autor:
Lisa W. M. Leung, Ryan J. Imhoff, Howard J. Marshall, Diana Frame, Peter J. Mallow, Laura Goldstein, Tom Wei, Maria Velleca, Hannah Taylor, Mark M. Gallagher
INTRODUCTION: Research evidence has shown that catheter ablation is a safe and superior treatment for atrial fibrillation (AF) compared to medical therapy, but real-world practice has been slow to adopt an early interventional approach. This study ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aedc67529ad4f20210f5dd01c123903f
Autor:
Dhiraj Gupta, Maria Velleca, Timothy Disher, Leena Patel, Kiefer Eaton, Tom De Potter, Laura Goldstein, Graça Costa, Daniel T. Grima
Publikováno v:
Journal of Comparative Effectiveness Research. 9:115-126
Atrial fibrillation (AF) ablation is most commonly performed using radiofrequency (RF) and cryoballoon (CB) catheters. Ablation Index is a novel lesion-quality marker associated with improved outcomes in RF ablation. Due to lack of direct comparative
Autor:
Graça Costa, Daniel T. Grima, Kiefer Eaton, Paul Spin, Laura Goldstein, Maria Velleca, Giuseppe Stabile, Leena Patel, Tom De Potter, Ahmed Hussein, Dhiraj Gupta
Publikováno v:
Advances in Therapy
Introduction Ablation Index, also known as VISITAG SURPOINT™, is a novel lesion-quality marker that improves outcomes in radiofrequency (RF) catheter ablation of atrial fibrillation (AF). There is no direct evidence on the comparative effectiveness
Publikováno v:
EMJ Cardiology. :110-118
Atrial fibrillation (AF), the most common form of arrhythmia, is fast becoming one of the world’s most significant health issues. It is well established that AF increases the risk of mortality, and is associated with significant morbidity, includin
Publikováno v:
EMJ Cardiology. :98-109
Atrial fibrillation (AF), the most common form of arrhythmia, increases the risk of heart failure, stroke, and death. Management of AF focusses on effectively and safely controlling irregular heart rhythm, improving symptoms, and reducing complicatio